98 related articles for article (PubMed ID: 10745610)
1. Vasoseal hemostasis following coronary interventions with abciximab.
Lunney L; Karim K; Little T
J Invasive Cardiol; 1999 Sep; 11 Suppl B():2B-3B. PubMed ID: 10745610
[TBL] [Abstract][Full Text] [Related]
2. Vasoseal hemostasis following coronary interventions with Abciximab.
Lunney L; Karim K; Little T
Cathet Cardiovasc Diagn; 1998 Aug; 44(4):405-6. PubMed ID: 9716204
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times.
Silber S; Björvik A; Mühling H; Rösch A
J Invasive Cardiol; 1999 Sep; 11 Suppl B():19B-24B. PubMed ID: 10745613
[TBL] [Abstract][Full Text] [Related]
5. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
[TBL] [Abstract][Full Text] [Related]
6. Collagen application for sealing of arterial puncture sites in comparison to pressure dressing: a randomized trial.
Schräder R; Steinbacher S; Burger W; Kadel C; Vallbracht C; Kaltenbach M
J Invasive Cardiol; 1999 Sep; 11 Suppl B():14B-18B. PubMed ID: 10745612
[TBL] [Abstract][Full Text] [Related]
7. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett).
Michalis LK; Rees MR; Patsouras D; Katsouras CS; Goudevenos J; Pappas S; Sourla E; Kolettis T; Sioros L; Zotou P; Gartzou-Matsouka P; Sideris DA
Cardiovasc Intervent Radiol; 2002; 25(5):423-9. PubMed ID: 12132030
[TBL] [Abstract][Full Text] [Related]
9. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access.
Choussat R; Black A; Bossi I; Fajadet J; Marco J
Eur Heart J; 2000 Apr; 21(8):662-7. PubMed ID: 10731404
[TBL] [Abstract][Full Text] [Related]
10. Achieving femoral artery hemostasis after cardiac catheterization: a comparison of methods.
Schickel SI; Adkisson P; Miracle V; Cronin SN
Am J Crit Care; 1999 Nov; 8(6):406-9. PubMed ID: 10553181
[TBL] [Abstract][Full Text] [Related]
11. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinski EJ; Roubin GS
J Am Coll Cardiol; 1993 Nov; 22(5):1273-9. PubMed ID: 8227779
[TBL] [Abstract][Full Text] [Related]
12. The use of the StarClose device for obtaining femoral artery hemostasis.
Rodriguez A; Katz SG
Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
[TBL] [Abstract][Full Text] [Related]
13. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635
[TBL] [Abstract][Full Text] [Related]
14. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
Assali AR; Sdringola S; Moustapha A; Ghani M; Salloum J; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
Catheter Cardiovasc Interv; 2003 Jan; 58(1):1-5. PubMed ID: 12508187
[TBL] [Abstract][Full Text] [Related]
15. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
Siudak Z; Zawislak B; Dziewierz A; Rakowski T; Jakala J; Bartus S; Noworolnik B; Zasada W; Dubiel JS; Dudek D
Coron Artery Dis; 2010 Aug; 21(5):292-7. PubMed ID: 20453640
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
[TBL] [Abstract][Full Text] [Related]
17. Reducing bedrest following arterial puncture for coronary interventional procedures--impact on vascular complications: the BAC Trial.
Vlasic W; Almond D; Massel D
J Invasive Cardiol; 2001 Dec; 13(12):788-92. PubMed ID: 11731689
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures.
Nader RG; Garcia JC; Drushal K; Pesek T
J Invasive Cardiol; 2002 Jun; 14(6):305-7. PubMed ID: 12042620
[TBL] [Abstract][Full Text] [Related]
19. Complications of cardiac catheterization in the current era: a single-center experience.
Chandrasekar B; Doucet S; Bilodeau L; Crepeau J; deGuise P; Gregoire J; Gallo R; Cote G; Bonan R; Joyal M; Gosselin G; Tanguay JF; Dyrda I; Bois M; Pasternac A
Catheter Cardiovasc Interv; 2001 Mar; 52(3):289-95. PubMed ID: 11246238
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
